Noramco, Inc.

Noramco is a leading specialty active pharmaceutical ingredient (API) development and manufacturing company that supports the advancement of opioid and non-opioid products in a range of therapeutic applications. Founded in 1979, the company is headquartered in Delaware and maintains operations around the world. Specialists in controlled substance development and manufacturing, Noramco is a partner to the pharmaceutical industry: delivering DEA-compliant security and production capacity, high-purity controlled substances, formulation-friendly particle size grades, and world-class supply security of controlled substances. They are leaders in Addiction Treatment and Abuse Prevention (ATAP) and trusted partners for comprehensive ADHD technology.

The Nombase Funding database has 4,288 records from over 1,788 companies.

There's no funding data for this company.